AstraZeneca PLC ADR (AZN) Social Stream
ASTRAZENECA PLC (AZN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ASTRAZENECA PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 7 | $73 | $66 | $69.1 | $68.91 | 0.28% |
| 2021-12-07 | 7 | $73 | $66 | $69.1 | $68.91 | 0.28% |
| 2022-01-17 | 7 | $73 | $60 | $67.1 | $68.91 | -2.63% |
| 2022-02-02 | 7 | $73 | $62.5 | $67.725 | $68.91 | -1.72% |
| 2022-02-10 | 7 | $69.4 | $62.5 | $65.725 | $68.91 | -4.62% |
| 2022-02-23 | 7 | $69.4 | $59.5 | $64.975 | $68.91 | -5.71% |
| 2022-02-24 | 7 | $70 | $59.5 | $66.225 | $68.91 | -3.9% |
| 2022-04-06 | 6 | $70 | $59.5 | $66.225 | $68.91 | -3.9% |
| 2022-04-11 | 5 | $82 | $59.5 | $69.375 | $68.91 | 0.67% |
| 2022-04-28 | 5 | $80 | $62 | $70.35 | $68.91 | 2.09% |
| 2022-04-30 | 5 | $82 | $62 | $73.5 | $68.91 | 6.66% |
| 2022-05-03 | 5 | $80 | $62 | $73 | $68.91 | 5.94% |
| 2022-06-06 | 5 | $80 | $59 | $73.5 | $68.91 | 6.66% |
| 2022-08-13 | 6 | $80 | $58.5 | $73.375 | $68.91 | 6.48% |
| 2022-10-05 | 7 | $80 | $58.5 | $73.7 | $68.91 | 6.95% |
| 2022-10-28 | 7 | $80 | $54.5 | $72.9 | $68.91 | 5.79% |
| 2022-11-11 | 7 | $80 | $54.5 | $73.5 | $68.91 | 6.66% |
| 2022-12-03 | 7 | $80 | $54.5 | $73.7 | $68.91 | 6.95% |
| 2022-12-12 | 7 | $88 | $54.5 | $75.3 | $68.91 | 9.27% |
| 2023-01-04 | 8 | $88 | $64.5 | $77.3 | $68.91 | 12.18% |
| 2023-04-18 | 9 | $88 | $64.5 | $78.083 | $68.91 | 13.31% |
| 2023-04-27 | 9 | $88 | $67 | $78.5 | $68.91 | 13.92% |
| 2023-06-07 | 9 | $88 | $67 | $78.166 | $68.91 | 13.43% |
| 2023-06-15 | 8 | $88 | $67 | $79.166 | $68.91 | 14.88% |
| 2023-07-07 | 9 | $88 | $66.5 | $79.083 | $68.91 | 14.76% |
| 2023-08-01 | 10 | $88 | $66.5 | $79.25 | $68.91 | 15.01% |
| 2023-09-12 | 10 | $88 | $66.5 | $80.3 | $68.91 | 16.53% |
| 2023-11-09 | 10 | $88 | $78 | $83 | $68.91 | 20.45% |
| 2023-11-17 | 10 | $88 | $77 | $82.8 | $68.91 | 20.16% |
| 2023-12-06 | 10 | $88 | $77 | $82.5 | $68.91 | 19.72% |
| 2023-12-18 | 10 | $88 | $77 | $81.75 | $68.91 | 18.63% |
The Trend in the Analyst Price Target
AZN's average price target has moved up $8.38 over the prior 17 months.
AZN reports an average of 15.61% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-16 | 8 | 88 | 64.5 | 78.083 | 67.95 | 14.91% |
| 2023-05-01 | 9 | 88 | 67.0 | 78.166 | 73.50 | 6.35% |
| 2023-09-11 | 10 | 88 | 66.5 | 80.300 | 66.60 | 20.57% |
| 2023-09-12 | 10 | 88 | 66.5 | 80.300 | 67.34 | 19.25% |
| 2023-11-09 | 10 | 88 | 78.0 | 83.000 | 64.09 | 29.51% |
AZN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 8 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 31 weeks, AZN's average broker recommendation rating improved by 0.26.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ASTRAZENECA PLC fares relative to stocks in the mega market cap category, note that its number of analysts covering the stock is higher than 172.11% of that group.
- In the context of Pharmaceutical Products stocks, ASTRAZENECA PLC's variance in analysts' estimates is lower than -393.89% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ASTRAZENECA PLC's upside potential (average analyst target price relative to current price) is higher than 721.59% of them.
- In the context of Pharmaceutical Products stocks, ASTRAZENECA PLC's average analyst price target is higher than 3046.45% of them.
Stocks similar to ASTRAZENECA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NVS, ABBV, and MRK.
View All Top Stocks by Price Target
Make investment decisions regarding AZN using the data that counts. Try POWR Ratings for free.